McKesson Corporation: 10-K Risk Factor Changes

2026 vs 2025  ·  SEC EDGAR  ·  2026-07-05
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

3
New Risks
4
Removed
11
Modified
27
Unchanged
🟢 New in Current Filing Severity9/10Det 9

McKESSON CORPORATION

us, or delay payments, or fail to pay amounts, owed to us. Suppliers might increase their prices, reduce their output, or change their terms of sale due to limited availability of credit. Suppliers might be unable to make payments due to us for fees, returned products, or…

Read full text

us, or delay payments, or fail to pay amounts, owed to us. Suppliers might increase their prices, reduce their output, or change their terms of sale due to limited availability of credit. Suppliers might be unable to make payments due to us for fees, returned products, or incentives. Interest rate increases or changes in capital market conditions, including as a result of macroeconomic events, might impede our or our customers’ or suppliers’ ability or cost to obtain credit. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.

🟢 New in Current Filing The adoption and use of AI in our business operations exposes us to risks and uncertainties. 🔒
🟢 New in Current Filing Our planned separation of Medical-Surgical Solutions is contingent upon the satisfaction of certain conditions, may not be completed on the currently contemplated terms or timeline, or at all, and, if completed, may not achieve the intended financial and strategic benefits. 🔒
🟡 Modified We may be unsuccessful in achieving our strategic growth objectives. 🔒
🟡 Modified From time to time we have difficulties in sourcing or selling products due to a variety of causes and are adversely impacted by disruptions or changes in product supply. 🔒
🟡 Modified We are subject to extensive, complex, challenging, and frequently changing healthcare, environmental, and other laws, and may experience increased costs to distribute controlled substances such as opioids. 🔒
🔴 No Match in Current Filing We experience increased costs to distribute controlled substances such as opioids. 🔒
🔴 No Match in Current Filing McKESSON CORPORATION 🔒
🔴 No Match in Current Filing McKESSON CORPORATION 🔒
🔴 No Match in Current Filing McKESSON CORPORATION 🔒
🟡 Modified We might be unable to successfully complete or integrate acquisitions or other strategic transactions, and our investments in businesses may not perform as we expect. 🔒
🟡 Modified Privacy, cybersecurity, data protection, and AI laws and guidance increase our compliance burden and expose us to risks. 🔒
🟡 Modified McKESSON CORPORATION 🔒
🟡 Modified We experience significant problems with information systems or networks. 🔒
🟡 Modified We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models. 🔒
🟡 Modified Our technology products or services might not conform to specifications or perform as we intend. 🔒
🟡 Modified Anti-bribery and anti-corruption laws increase our compliance burden and expose us to risks. 🔒
🟡 Modified INDEX TO RISK FACTORS 🔒
17 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get full access — from $29/month Already a Pro subscriber? View full diff →